Industry
Medical - Instruments & Supplies
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Newsdesk
March 18, 2024 | 8:38 pm
Portfolio Pulse from Benzinga Insights
March 18, 2024 | 9:57 am
Portfolio Pulse from Benzinga Insights
March 15, 2024 | 3:01 pm
Portfolio Pulse from Benzinga Insights
February 09, 2024 | 9:31 pm
Portfolio Pulse from Benzinga Newsdesk
January 23, 2024 | 2:20 pm
Portfolio Pulse from Benzinga Newsdesk
January 22, 2024 | 12:50 pm
Portfolio Pulse from Benzinga Newsdesk
January 07, 2024 | 10:26 pm
Portfolio Pulse from Benzinga Insights
November 14, 2023 | 9:30 pm
Portfolio Pulse from vinayak@benzinga.com
November 14, 2023 | 9:28 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.